ACUTE LYMPHOBLASTIC LEUKEMIA, ADULT
Clinical trials for ACUTE LYMPHOBLASTIC LEUKEMIA, ADULT explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOBLASTIC LEUKEMIA, ADULT trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOBLASTIC LEUKEMIA, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to boost survival in adult leukemia
Disease control Recruiting nowThis study is testing a powerful chemotherapy regimen originally designed for children, combined with the targeted drug venetoclax and immunotherapy, in adults aged 14 to 60 with a certain type of acute lymphoblastic leukemia (ALL). The goal is to see if this approach can achieve…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA, ADULT
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New study opens door for CAR t therapy in patients with kidney disease
Disease control Recruiting nowThis study looks at whether CAR T cell therapy, a type of cancer treatment that uses a patient's own immune cells, can be safely given to people with moderate to severe kidney problems. The trial involves 20 adults with blood cancers like lymphoma, myeloma, or leukemia. Before ge…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA, ADULT
Phase: PHASE2 • Sponsor: Northside Hospital, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New combo therapy aims to cut chemo and boost survival in leukemia
Disease control Recruiting nowThis study tests whether adding CAR-T cells to standard chemotherapy can help adults newly diagnosed with a certain type of leukemia (Ph-negative B-ALL) achieve deeper remission and need fewer chemo cycles. About 77 participants will receive CAR-T cells after initial chemo. The g…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA, ADULT
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Triple threat: targeted drugs + CAR-T cells aim to beat a tough leukemia
Disease control Recruiting nowThis clinical trial is testing a new treatment approach for adults newly diagnosed with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). The treatment combines targeted drugs (olverembatinib and venetoclax) with reduced-intensity chemotherapy, followed by …
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA, ADULT
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC